Circulating MicroRNAs As Biomarkers of Chagas Cardiomyopathy

Overview

Journal Front Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2024 Jan 4

PMID 38173812

Authors

Laura Antonietti

Javier Mariani

Maria Jose Martinez

Manuela Santalla

Natalia Vensentini

Diego Alfredo Kyle

Maximiliano De Abreu

Carlos Tajer

Ezequiel Lacunza

Paola Ferrero

Affiliations

Soon will be listed here.

Abstract

Background: Chagas cardiomyopathy (CHCM) is the most important clinical manifestation of Chagas disease. The analysis of cardiac miRNAs may contribute to predicting the progression to CHCM in Chagas indeterminate phase and/or to the differential diagnosis for cardiomyopathy.

Methods: We carried out a case-control study to identify circulating miRNAs associated with CHCM. We assigned 104 participants to four groups: healthy controls (HC), Chagas non-cardiomyopathy controls, CHCM cases, and ischemic cardiomyopathy controls. We performed a clinical, echocardiographic, and laboratory evaluation and profiled circulating miRNA in the serum samples.

Results: Differences between groups were observed in clinical variables and in the analysis of miRNAs. Compared to HC, CHCM participants had 4 over-expressed and 6 under-expressed miRNAs; miR-95-3p and miR-130b-3p were upregulated in CHCM compared with controls, Chagas non-cardiomyopathy and ischemic cardiomyopathy participants, suggesting that might be a hallmark of CHCM. Analysis of gene targets associated with cardiac injury yielded results of genes involved in arrhythmia generation, cardiomegaly, and hypertrophy.

Conclusions: Our data suggest that the expression of circulating miRNAs identified by deep sequencing in CHCM could be associated with different cardiac phenotypes in CHCM subjects, compared with Chagas non-CHCM, ischemic cardiomyopathy controls, and healthy controls.

References

Smith-Vikos T, Slack F . MicroRNAs and their roles in aging. J Cell Sci. 2012; 125(Pt 1):7-17. PMC: 3269020. DOI: 10.1242/jcs.099200. View

Naipauer J, Sola M, Salyakina D, Rosario S, Williams S, Coso O . A Non-Coding RNA Network Involved in KSHV Tumorigenesis. Front Oncol. 2021; 11:687629. PMC: 8242244. DOI: 10.3389/fonc.2021.687629. View

Kayyali U, Larsen C, Bashiruddin S, Lewandowski S, Trivedi C, Warburton R . Targeted deletion of Tsc1 causes fatal cardiomyocyte hyperplasia independently of afterload. Cardiovasc Pathol. 2014; 24(2):80-93. PMC: 4344870. DOI: 10.1016/j.carpath.2014.10.005. View

Gomez-Ochoa S, Bautista-Nino P, Rojas L, Hunziker L, Muka T, Echeverria L . Circulating MicroRNAs and myocardial involvement severity in chronic Chagas cardiomyopathy. Front Cell Infect Microbiol. 2022; 12:922189. PMC: 9393411. DOI: 10.3389/fcimb.2022.922189. View

Subramanian A, Tamayo P, Mootha V, Mukherjee S, Ebert B, Gillette M . Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005; 102(43):15545-50. PMC: 1239896. DOI: 10.1073/pnas.0506580102. View

Ribeiro A, Nunes M, Teixeira M, Rocha M . Diagnosis and management of Chagas disease and cardiomyopathy. Nat Rev Cardiol. 2012; 9(10):576-89. DOI: 10.1038/nrcardio.2012.109. View

Navarro I, Ferreira F, Nakaya H, Baron M, Vilar-Pereira G, Resende Pereira I . MicroRNA Transcriptome Profiling in Heart of Trypanosoma cruzi-Infected Mice: Parasitological and Cardiological Outcomes. PLoS Negl Trop Dis. 2015; 9(6):e0003828. PMC: 4473529. DOI: 10.1371/journal.pntd.0003828. View

Linhares-Lacerda L, Granato A, Gomes-Neto J, Conde L, Freire-de-Lima L, de Freitas E . Circulating Plasma MicroRNA-208a as Potential Biomarker of Chronic Indeterminate Phase of Chagas Disease. Front Microbiol. 2018; 9:269. PMC: 5845676. DOI: 10.3389/fmicb.2018.00269. View

Silva D, Carneiro F, Almeida K, Fernandes-Santos C . Role of miRNAs on the Pathophysiology of Cardiovascular Diseases. Arq Bras Cardiol. 2018; 111(5):738-746. PMC: 6248252. DOI: 10.5935/abc.20180215. View

10.

Mir R, Elfaki I, Khullar N, Waza A, Jha C, Mir M . Role of Selected miRNAs as Diagnostic and Prognostic Biomarkers in Cardiovascular Diseases, Including Coronary Artery Disease, Myocardial Infarction and Atherosclerosis. J Cardiovasc Dev Dis. 2021; 8(2). PMC: 7923109. DOI: 10.3390/jcdd8020022. View

11.

Toffolo K, Osei J, Kelly W, Poulsen A, Donahue K, Wang J . Circulating microRNAs as biomarkers in traumatic brain injury. Neuropharmacology. 2018; 145(Pt B):199-208. DOI: 10.1016/j.neuropharm.2018.08.028. View

12.

Guo L, Zhang Q, Ma X, Wang J, Liang T . miRNA and mRNA expression analysis reveals potential sex-biased miRNA expression. Sci Rep. 2017; 7:39812. PMC: 5206641. DOI: 10.1038/srep39812. View

13.

Ooi J, Bernardo B, McMullen J . The therapeutic potential of miRNAs regulated in settings of physiological cardiac hypertrophy. Future Med Chem. 2014; 6(2):205-22. DOI: 10.4155/fmc.13.196. View

14.

Nonaka C, Macedo C, Cavalcante B, Alcantara A, Silva D, da Rocha Bezerra M . Circulating miRNAs as Potential Biomarkers Associated with Cardiac Remodeling and Fibrosis in Chagas Disease Cardiomyopathy. Int J Mol Sci. 2019; 20(16). PMC: 6721092. DOI: 10.3390/ijms20164064. View

15.

Talvani A, Rocha M, Barcelos L, Gomes Y, Ribeiro A, Teixeira M . Elevated concentrations of CCL2 and tumor necrosis factor-alpha in chagasic cardiomyopathy. Clin Infect Dis. 2004; 38(7):943-50. DOI: 10.1086/381892. View

16.

Friedman R, Farh K, Burge C, Bartel D . Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2008; 19(1):92-105. PMC: 2612969. DOI: 10.1101/gr.082701.108. View

17.

Pathan M, Keerthikumar S, Ang C, Gangoda L, Quek C, Williamson N . FunRich: An open access standalone functional enrichment and interaction network analysis tool. Proteomics. 2015; 15(15):2597-601. DOI: 10.1002/pmic.201400515. View

18.

Nyegaard M, Overgaard M, Sondergaard M, Vranas M, Behr E, Hildebrandt L . Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death. Am J Hum Genet. 2012; 91(4):703-12. PMC: 3484646. DOI: 10.1016/j.ajhg.2012.08.015. View

19.

Bayraktar R, Van Roosbroeck K, Calin G . Cell-to-cell communication: microRNAs as hormones. Mol Oncol. 2017; 11(12):1673-1686. PMC: 5709614. DOI: 10.1002/1878-0261.12144. View

20.

Love M, Huber W, Anders S . Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014; 15(12):550. PMC: 4302049. DOI: 10.1186/s13059-014-0550-8. View